Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion

International Journal of Colorectal Disease

Volumn 20, Issue 3, 2005, Pages 258-261

  Arkenau, H T ^a   Rettig, K ^b   Porschen, Rainer ^a  

^a General Hospital Bremen East   (Germany)

^b GEM   (Germany)

Author keywords

5 Fluorouracil leucovorin; Adjuvant chemotherapy; Colon cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; BOLUS INJECTION; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLON CARCINOMA; COLON RESECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REGIMEN; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; STOMATITIS; TUMOR RECURRENCE; VOMITING;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 17544374369     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-004-0657-6     Document Type: Article

References (16)

1. Pisani P, Parkin DM, Bray F et al (1999) Estimates of the worldwide mortality of twenty-five major cancers in 1990. Int J Cancer 83:18-29
2. Sant M, Capocaccia R, Verdecchia A et al (1995) Comparison of colon cancer survival among European countries: The EUROCARE study. Int J Cancer 63:43-48
3. Hermanek P, Wiebelt H, Riedl S et al (1994) Long-time results of surgical therapy for colorectal cancer: Results of the German Study Group for Colorectal Cancer (SGCRC). Chirurg 65:287-297
4. Zalcberg JR, Siderov J, Simes J (1996) The role of 5-fluorouracil in the adjuvant therapy of colorectal cancer. Ann Oncol 7:41-46
5. Ardalan B, Chua L, Tian EM, Reddy R, Sridhar K, Benedetto P, Richman S, Legaspi A, Waldman S, Morrell L (1991) A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma. J Clin Oncol 9:625-630
6. Leichmann CG, Fleming TR, Muggia FM et al (1995) Phase II study of fluorouracil and its modulation in advanced colorectal cancer: A southwest oncology group study. J Clin Oncol 13:1303-1311
7. O'Dwyer PJ, Ryan LM, Valone FH et al (1996) Phase III trial of biochemical modulation of 5-fluorouracil by iv or oral leucovorin or by interferon in advanced colorectal cancer: An ECOG/CALGB phase III trial. Proc ASCO A469
8. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
9. Porschen R, Bermann A, Löffler T et al (2001) Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: Results of the trial adjCCA-01. J Clin Oncol 19:1787-1794
10. Arkenau HT, Bermann A, Rettig K et al (2003) 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: Long-term follow-up results of the adjCCA-01 trial. Ann Oncol 14:395-399
11. Andre T, Colin P, Louvet C et al (2003) Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: Results of a randomized trial. J Clin Oncol 21:2896-2903
12. De Gramont A, Banzi M, Navarro M et al (2003) Oxaliplatin/5-FU/LV in adjuvant colon cancer: Results of the international randomized MOSAIC trial. Proc ASCO A1015
13. Scheithauer W, McKendrick J, Begbie S et al (2003) Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: Safety results of a randomized, phase III trial. Ann Oncol 14:1735-1743
14. Cassidy J (2004) On behalf of the X-ACT Investigators: Capecitabine versus bolus 5-FU/LV as adjuvant therapy for colon cancer (the X-ACT study): Positive efficacy results of phase III results. Proc ASCO A3509
15. Lezoche E, Felicotti F, Guerrieri M et al (2003) Laparoscopic versus open hemicolectomy. Minerva Chir 4:491-502
16. Martenson JA, Willett CG, Sargent DJ et al (2004) Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: Results of intergroup protocol 0130. J Clin Oncol 22:3277-3283